)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Vivani Medical (VANI) investor relations material
Vivani Medical Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Advanced ultra long-acting subdermal drug implants using NanoPortal technology, with lead programs NPM-139 (semaglutide implant) and NPM-133 targeting obesity and type 2 diabetes.
NPM-139 showed ~20% weight loss in preclinical studies; Phase 1 clinical trials planned for H1 2026, with rapid Phase 2 initiation pending results.
LIBERATE-1, the first-in-human trial of NPM-115, met safety and tolerability endpoints, supporting further platform development.
Strategic shift to prioritize obesity portfolio and rapid advancement of NPM-139 based on positive data.
Only company developing ultra long-acting miniature GLP-1 implants for once- or twice-yearly dosing to improve adherence in obesity treatment.
Financial highlights
Net loss for Q3 2025 was $6.5 million, compared to $6.0 million in Q3 2024; net loss for the nine months ended September 30, 2025 was $20.0 million.
Operating expenses for Q3 2025 were $6.7 million, up 7% year-over-year, with R&D at $4.5 million and G&A at $2.2 million.
Cash, cash equivalents, and restricted cash totaled $4.0 million as of September 30, 2025, down from $19.7 million at year-end 2024.
Gross proceeds of $25.7 million from private placements and financings in Q3 and October 2025.
Working capital decreased to negative $2.7 million as of September 30, 2025.
Outlook and guidance
Current cash and committed capital expected to fund operations into 2027, with $18.6 million in additional equity purchase agreements through July 2026.
Plans to initiate Phase 1 clinical study for NPM-139 in H1 2026, pending regulatory clearance.
Expects to complete the spin-off of Cortigent as an independent public company after SEC operations resume.
Ongoing need for substantial additional financing to support clinical development and commercialization.
How do recent financings extend cash runway?
How does NanoPortal address adherence/tolerability?
What are the strategic options for Cortigent?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Vivani Medical earnings date
Q4 202527 Mar, 2026
Next Vivani Medical earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Vivani Medical Inc. is a biopharmaceutical company focused on developing innovative solutions for chronic disease management through the use of miniaturized, long-term subdermal drug implants. The company's proprietary NanoPortal™ technology enables the steady release of medications over extended periods, addressing key issues such as medication non-adherence and fluctuating drug levels. The company is headquartered in Alameda, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage